Not checkedNot checked for notices yet.
Adenosine receptor 2a agonists target mouse CD11c+T-bet+ B cells in infection and autoimmunity
Russell C. Levack, Krista L. Newell, Berenice Cabrera-Martinez and 4 more
Nature Communications · 2022
doi:10.1038/s41467-022-28086-1 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
CD11c+T-bet+ B cells have been linked with different autoimmune diseases, but targeting these cells has been challenging. Here the authors use an adenosine 2A receptor agonist to deplete these B cells and to inhibit or reverse autoimmune symptoms and pathology in mice.
Abstract licence: CC BY-NC-ND
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.